Pay in 4 interest-free payments of $200.38 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
CircLigase ssDNA Ligase ligates ends of ssDNA in the absence of a complementary sequence
biocompatibility and sterility
The unprecedented transformation efficiency of E
commonly manufactured in E
activation of hTLR4/MD-2 signalling by ClearColi is several orders of magnitude lower compared with E
ClearColi-BL21(DE3) Electrocompetent Cells (DUOs) size:12 rxns CircLigase ssDNA Ligase ligates endsClearColi BL21(DE3) Electrocompetent Cells Eliminate endotoxin at the source Genetically modified LPS does not trigger endotoxic response in human cells Ideal for mammalian cell immunogenicity testing, toxicity assays, and therapeutic protein drug discovery Useful for membrane and lipid binding protein production Protein expression similar to BL21(DE3) cells without requiring downstream endotoxin removal Reduce false positives in cytokine assays,